Catalyst Pharmaceuticals (CPRX) Financial Statements & Analysis

Catalyst Pharmaceuticals (CPRX) Income Statement

Catalyst Pharmaceuticals reported revenue of $588.99M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 19.8% from $491.73M a year earlier. Net income was $214.33M, up 30.8% year over year, a net margin of 36.4%. Gross margin was 85.2% and operating margin 43.8%. In the most recent quarter, Q1 fiscal 2026 (ended Mar 31, 2026), revenue was $149.39M, up 5.6% from the same quarter a year earlier.

Catalyst Pharmaceuticals Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Catalyst Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	588.99	491.73	398.20	214.20	140.83	119.07	102.31	0.50	0.00
Cost of Revenue	99.96	68.85	51.97	34.39	38.82	17.04	14.76	19.92	0.05
Gross Profit	501.74	422.89	346.24	179.81	118.95	102.03	87.55	-19.42	-0.05
Operating Expenses
Research & Development	12.71	12.65	93.15	19.79	16.94	16.50	18.84	19.92	11.38
Selling, General & Administrative	193.75	177.74	133.71	57.09	49.63	44.23	36.88	15.88	7.30
Operating Expenses	243.96	227.77	259.43	77.97	66.56	60.73	55.72	35.80	18.68
Operating Income	257.78	195.12	86.81	101.84	52.39	41.30	31.82	-35.30	-18.68
Other Income/Expense
Interest Income	0.00	16.06	0.00	0.00	0.28	0.00	1.59	1.29	0.45
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.45
Other Income/Expense	25.74	5.08	7.70	2.88	0.28	0.59	1.59	1.29	0.27
Income
Income Before Tax	283.52	216.26	94.51	104.72	52.67	41.89	33.41	-34.00	-18.41
Income Tax Expense	69.19	52.37	23.10	21.64	13.19	-33.09	1.53	0.00	0.14
Net Income	214.33	163.89	71.41	83.08	39.48	74.98	31.88	-34.00	-18.41
Net Income - Continuous Operations	214.33	163.89	71.41	83.08	39.48	74.98	31.88	-34.00	-18.41
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	295.65	232.90	127.39	103.08	52.58	41.40	31.88	-35.26	-18.49
EBIT	257.78	195.12	86.81	101.84	52.39	41.30	-	-	-
Depreciation & Amortization	37.87	37.38	32.88	1.10	0.19	0.09	0.06	0.04	0.05
Earnings Per Share
Basic EPS	2.00	1.00	1.00	1.00	-	1.00	-	-	-
Diluted EPS	2.00	1.00	1.00	1.00	-	1.00	-	-	-
Basic Shares Outstanding	122.29	118.46	106.28	103.37	103.38	103.51	102.94	102.63	85.80
Diluted Shares Outstanding	127.26	124.94	113.75	111.38	107.80	106.24	106.02	102.63	85.80

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Catalyst Pharmaceuticals Financial Statements

What was Catalyst Pharmaceuticals's revenue in fiscal 2025?

Catalyst Pharmaceuticals reported revenue of $588.99M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 19.8% from $491.73M a year earlier.

Is Catalyst Pharmaceuticals profitable?

Yes. Catalyst Pharmaceuticals earned net income of $214.33M in fiscal 2025, a net margin of 36.4%. In fiscal 2024 it earned $163.89M.

What is Catalyst Pharmaceuticals's operating margin?

Catalyst Pharmaceuticals's operating income was $257.78M on revenue of $588.99M in fiscal 2025, an operating margin of 43.8%, compared with 39.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition